N-(3-((3-(trifluoromethyl)phenyl)selanyl)prop-2-yn-1-yl) benzamide ameliorates lipopolysaccharide-induced depression-like behavior in mice targeting inflammatory, apoptotic, and oxidative pathways
{{output}}
The organoselenium compound CF3SePB has previously shown promise as an antidepressant due to its modulation of the serotonergic system. This study aimed to investigate the potential of CF3SePB to ameliorate depressive-like behaviors induced by lipopolysacchari... ...
